The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Python

RUE CHARLES-BONNET 2, 1206 GENEVA, SWITZERLAND
Tel:
Work +41 22 702 15 15
Fax:
Fax +41 22 702 14 14
Email:
Web:
www.pplex.ch
Bern, Brussels, Geneva, Lausanne, Sion, Tehran and 2 more

The firm

Python is one of the major full-scope Swiss firms in terms of size and resources with the know-how and facilities to enable it to play a significant role on the Swiss and international scene. Originally founded in Geneva by four partners in 1981, the firm now also has offices in Lausanne, Bern, Sion and Zug. In 1998, the firm opened an office in Tokyo, becoming the first Swiss law firm to be accredited by the Tokyo Bar. In order to have a link to the EU, a liaison office was also established in Brussels. In 2016, Python became the first ever Swiss law firm to launch an office in Tehran. Effective 1 July 2016, Python & Peter became Python, reflecting the evolution of the firm’s identity in the marketplace. High quality, efficiency, responsiveness and flexibility are the firm’s guiding principles. With its cadre of over 70 experienced, multilingual lawyers, the firm offers legal services in 11 practice areas. The firm’s clients include major international corporations, financial institutions, startups, partnerships and private individuals from Switzerland and all over the world.

Areas of practice

Arbitration: the eminent team has developed extensive expertise serving as counsel or arbitrators in prominent cases under the rules of all the major arbitration institutions and systems, including ICC, LCIA, Swiss Rules, SCC, VIAC, WTO, WIPO, ICSID, CAS and UNCITRAL, as well as in ad hoc matters.

Banking and finance: the noted team deals with a broad range of activities, including the setup and licensing of Swiss banks, subsidiaries, local offices of foreign banks and securities dealers, regulations on anti-money laundering, compliance, enforcement and disclosure matters.

Commercial contracts: the renowned team advises on cross-border transactions and investments, contractual or equity joint ventures, the sale and purchase of business assets, transaction structuring, shipping, raw material trading, maritime and commodities trading, cargo claims, charter party disputes, vessel purchase, registration and sale transactions.

Corporate and M&A: the notable corporate and M&A team advises on mergers, acquisitions and reorganisations, sale of companies and management and ownership successions, stock and asset purchase agreements, negotiations of representations and warranties, disclosure schedules and side agreements, and financing documents.

Employment and immigration: the employment team advises on contracts, maternity/paternity rights, settlement agreements, unfair dismissal claims, redundancies, disciplinary and grievance procedures, individual and mass layoffs, and mediation and litigation. The immigration team assists with work permits, self-employed persons, students, trainees, permit renewals/extensions, changes of canton, job, marital status, departures, official certificates/statements and customs clearances.

IP, IT and telecoms: the acclaimed team advises on patents, trade marks, design and copyright, know-how and trade secret issues, media privacy, advertising law, e-commerce, software and IT matters, in particular domain names, website terms/conditions and data protection policies.

International legal assistance and criminal law: the expert team advises on such matters as international police cooperation, Interpol notices, information exchange between financial regulatory authorities, enforcement of embargos, international assistance in civil matters etc.

Litigation and insolvency: the outstanding team represents clients before all civil, commercial and administrative courts, covering commercial disputes including banking cases, insolvency matters, bankruptcy and debt collection litigation, private insurance litigation, estate/employment disputes, foreign judgments, antitrust and unfair competition litigation.

Private clients: the illustrious team advises on legal/tax issues, including on inheritance law, estate planning, taxes, domiciliation and naturalisation of foreign citizens in Switzerland, and assists with incorporating and administrating all vehicles used in estate planning.

Real estate and construction: the reputable team supports institutional investors, commercial users and private clients in purchase and lease of commercial and residential real estate, sale and lease-back transactions, general contractor agreements and construction contracts.

Tax: the distinguished tax team advises on the full range of Swiss federal, cantonal, inter-cantonal and international taxation matters.

  • Other offices
  • Bern
  • Brussels
  • Lausanne-Pully
  • Sion
  • Tehran
  • Tokyo
  • Zug
  • Number of lawyers: 75
  • at this office: 58
  • Languages
  • English
  • French
  • German
  • Spanish
  • Dutch
  • Hebrew
  • Italian
  • Japanese
  • Polish
  • Portuguese
  • Russian
  • Gujarati
  • Farsi

Above material supplied by Python.

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Awarded "Law Firm of the Year - Switzerland" at the Citywealth Magic Circle Awards 201

    Bär & Karrer is pleased to announce that it has received the award “Law Firm of the Year - Switzerland” at the Citywealth Magic Circle Awards in London. This award recognizes Bär & Karrer as the Swiss law firm with the best private client team.
  • Bär & Karrer Advises Ashcroft on the Acquisition of Rüeger Holding

    Ashcroft Inc., headquartered in Stratford, CT, USA, a subsidiary of Tokyo Stock Exchange listed Nagano Keiki Co., Ltd, has announced the completion of the acquisition of Swiss-based Rüeger Holding SA (Rüeger) and Dutch-based STIKO Meetapparentenfabriek B.V. (Stiko), both manufacturers of specialty temperature and pressure measurement products, from their previous owners, Bernard and Jean-Marc Rüeger.
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.